Colectomy Clinical Trial
— AGORAOfficial title:
Evaluation of the Benefit of Non-opioid General Anaesthesia on Postoperative Pain in Laparoscopic Colonic Surgery
Verified date | December 2023 |
Source | GCS Ramsay Santé pour l'Enseignement et la Recherche |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Evaluation of the benefit of non-opioid general anaesthesia on postoperative pain in laparoscopic colonic surgery
Status | Completed |
Enrollment | 160 |
Est. completion date | February 17, 2023 |
Est. primary completion date | February 17, 2023 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Patient over 18 years of age who has read and signed the consent form for participation in the study - Patient candidate for laparoscopic colectomy (planned or emergency) with possible conversion to laparotomy Exclusion Criteria: - Severe renal failure with baseline clearance<30, hepatic failure with baseline PT<40%, cardiac failure with LVEF<20%. - Patient under court protection, guardianship or curatorship - Pregnant or breastfeeding patient - Patient not affiliated to the French social security system - Impossible to give the subject informed information and/or to give written informed consent: dementia, psychosis, disturbed consciousness, non-French speaking patient - Contraindication to anaesthesia or to the administration of one of the products used in the anaesthesia protocol - Patient participating in another interventional research or in a period of exclusion from a previous research |
Country | Name | City | State |
---|---|---|---|
France | Hôpital Privé Médipôle | Villeurbanne |
Lead Sponsor | Collaborator |
---|---|
GCS Ramsay Santé pour l'Enseignement et la Recherche |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Morphine Use | All intravenous and oral morphine consumed in the first 48 hours after surgery | 48 hours | |
Secondary | Postoperative pain H12 | Postoperative pain will be reported by the nursing staff on a simple numerical scale graduated from 0 to 10 after questioning the patient, according to the usual procedures of the department. | Hour 12 | |
Secondary | Postoperative pain H24 | Postoperative pain will be reported by the nursing staff on a simple numerical scale graduated from 0 to 10 after questioning the patient, according to the usual procedures of the department. | Hour 24 | |
Secondary | Postoperative pain H36 | Postoperative pain will be reported by the nursing staff on a simple numerical scale graduated from 0 to 10 after questioning the patient, according to the usual procedures of the department. | Hour 36 | |
Secondary | Postoperative pain H48 | Postoperative pain will be reported by the nursing staff on a simple numerical scale graduated from 0 to 10 after questioning the patient, according to the usual procedures of the department. | Hour 48 | |
Secondary | Postoperative pain D30 | Postoperative pain will be reported by the nursing staff on a simple numerical scale graduated from 0 to 10 after questioning the patient, according to the usual procedures of the department. | Day 30 | |
Secondary | Mean arterial pressure | Mean arterial pressure (MAP) (mmHg) | 48 hours | |
Secondary | Mean arterial pressure variability | MAP variability in percentage | 48 hours | |
Secondary | Duration of Mean arterial pressure <65 | Duration of Mean arterial pressure <65 mmHg (min) | 48 hours | |
Secondary | Duration of Mean arterial pressure <55 | Duration of Mean arterial pressure <65 mmHg (min) | 48 hours | |
Secondary | Average heart rate | Average heart rate | 48 hours | |
Secondary | Heart rate variability | Heart rate variability in percentage | 48 hours | |
Secondary | Bradycardia duration < 50 | Bradycardia duration < 50 (min) | 48 hours | |
Secondary | Atropine dose administered | Atropine dose administered (mg) | 48 hours | |
Secondary | Ephedrine dose administered | Ephedrine dose administered (mg) | 48 hours | |
Secondary | Noradrenaline dose administered | Noradrenaline dose administered (ug) | 48 hours | |
Secondary | Neosynephrine dose administered | Neosynephrine dose administered (ug) | 48 hours | |
Secondary | Urapidil dose | Urapidil dose (mg) | 48 hours | |
Secondary | Nicardipine dose | Nicardipine dose (mg) | 48 hours | |
Secondary | Postoperative hypoxemia | Postoperative hypoxemia (Yes/No) | 48 hours | |
Secondary | Consumption of non-morphine drug | Consumption of NSAIDs, nefopam, tramadol, ondansetron and other antiemetics | Day 90 | |
Secondary | Assessment of tolerance | All adverse events will be collected and compared between the 2 groups | Day 90 | |
Secondary | Assessment of disability | Assessment of disability with the World Health Organization Disability Assessment Schedule (WHODAS2.0) | Day 30 | |
Secondary | Assessment of disability | Assessment of disability with the World Health Organization Disability Assessment Schedule (WHODAS2.0). Evolution between Day 30 and Day 90. | Day 90 | |
Secondary | Time to extubation, time to resumption of transit, time to onset of first gas, length of stay in ICU and total length of hospital stay | Time to extubation, time to resumption of transit, time to onset of first gas, length of stay in ICU and total length of hospital stay | Day 90 at least | |
Secondary | Immediate postoperative hypoxemia | Immediate postoperative hypoxemia | Day 1 | |
Secondary | Oxygen requirement | Oxygen requirement (yes/no at D0, D1, D2) | Day 2 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02065661 -
Product Validation Study of 2 New Devices, EZ-NG (RightSpot pH Indicator) and EZ-pH (RightLevel pH Indicator)
|
N/A | |
Completed |
NCT00827931 -
Study Of Tranexamic Acid For The Reduction Of Blood Loss In Patients Undergoing Major Abdominal Surgery
|
Phase 4 | |
Terminated |
NCT00139607 -
Parecoxib In Post Surgery (Hemicolectomy) Pain
|
Phase 3 | |
Completed |
NCT03827291 -
QL Block With Exparel in Colectomy
|
Phase 4 | |
Completed |
NCT02543190 -
System-Wide Improvement for Transitions After Surgery: The SWIFT Post op Program
|
N/A | |
Completed |
NCT00911391 -
Randomised Trial of Doppler-Optimised Fluid Balance in Elective Colectomy
|
Phase 3 | |
Recruiting |
NCT03650517 -
Minimally Invasive Right Colectomy Anastomosis Study
|
||
Terminated |
NCT03638635 -
Standard Bupivacaine vs Liposomal Bupivacaine in Colorectal Patients
|
Phase 4 | |
Recruiting |
NCT03722121 -
Is the Distance of Patients From Rouen University Hospital Influencing the Time Between Colectomy and First Chemotherapy Cure for Colon Cancer?
|
||
Completed |
NCT01079442 -
Coffee Trial - Does Coffee Intake Reduce Postoperative Ileus After Elective Colectomy?
|
N/A | |
Completed |
NCT00531739 -
SurgiWrapTM to Reduce Soft Tissue Attachment & Incidence Early Post-Operative Bowel Obstruction in Colorectal Surgery
|
Phase 4 | |
Recruiting |
NCT03552913 -
Enhanced Recovery After Surgery for Total Knee Arthroplasty, Left Colectomy and Hysterectomy
|
||
Completed |
NCT02509910 -
Implementation of a GDT Algorithm for Major Surgery Patients
|
N/A | |
Completed |
NCT04845334 -
Complementary and Alternative Medicine Interventions in Targeting Pain
|
N/A | |
Completed |
NCT03990714 -
Intracorporeal Vs Extracorporeal Anastomosis in Laparoscopic Right Hemicolectomy
|
N/A | |
Recruiting |
NCT05200806 -
A Prospective Pilot Study of a Non-Narcotic Post-Operative Course After Colectomy
|
Phase 4 | |
Completed |
NCT03216239 -
SIBO & SIFO After Colectomy
|
||
Not yet recruiting |
NCT02596516 -
A Comparison of Colonic Bile Acid Content Following Right and Left Colectomies
|
N/A | |
Active, not recruiting |
NCT05150548 -
Predictive Time-to-Event Model for Major Medical Complications After Colectomy
|
||
Recruiting |
NCT03367988 -
Opioid Free Anesthesia vs. Opioid Anesthesia Techniques.
|
Phase 2/Phase 3 |